Literature DB >> 6648524

Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen.

K Y Hui, E Haber, G R Matsueda.   

Abstract

A synthetic heptapeptide from the amino terminus of the beta chain in human fibrin was used as an antigen to produce monoclonal antibodies that bind to fibrin even in the presence of human fibrinogen at the concentration found in plasma. As expected, the antifibrin activity was inhibited by the peptide antigen but not by a control heptapeptide. In a chicken ex vivo circulatory model for fibrin detection, intravenously administered monoclonal antibodies bound to human fibrin-coated disks placed in an extracorporeal chamber. These findings may lead to better methods for identifying deep vein and coronary artery thrombi.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648524     DOI: 10.1126/science.6648524

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  68 in total

Review 1.  The use of cleavage site specific antibodies to delineate protein processing and breakdown pathways.

Authors:  J S Mort; D J Buttle
Journal:  Mol Pathol       Date:  1999-02

2.  Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain.

Authors:  L A Bunce; L A Sporn; C W Francis
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

3.  Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging.

Authors:  Andrew F Kolodziej; Shrikumar A Nair; Philip Graham; Thomas J McMurry; Robert C Ladner; Charles Wescott; Daniel J Sexton; Peter Caravan
Journal:  Bioconjug Chem       Date:  2012-02-09       Impact factor: 4.774

Review 4.  Immunoscintigraphy of thrombosis.

Authors:  M N Wasser; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

5.  Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.

Authors:  Hadil Owaynat; Ivan S Yermolenko; Ramya Turaga; Valeryi K Lishko; Michael R Sheller; Tatiana P Ugarova
Journal:  Thromb Res       Date:  2015-10-09       Impact factor: 3.944

Review 6.  Normal and abnormal transformation of the spiral arteries during pregnancy.

Authors:  Jimmy Espinoza; Roberto Romero; Yeon Mee Kim; Juan Pedro Kusanovic; Sonia Hassan; Offer Erez; Francesca Gotsch; Nandor Gabor Than; Zoltan Papp; Chong Jai Kim
Journal:  J Perinat Med       Date:  2006       Impact factor: 1.901

7.  A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.

Authors:  M S Runge; T Quertermous; P J Zavodny; T W Love; C Bode; M Freitag; S Y Shaw; P L Huang; C C Chou; D Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 8.  Antibody imaging in the evaluation of cardiovascular diseases.

Authors:  B A Khaw; J Narula
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

9.  An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia.

Authors:  Alfica Sehgal; Scott Barros; Lacramioara Ivanciu; Brian Cooley; June Qin; Tim Racie; Julia Hettinger; Mary Carioto; Yongfeng Jiang; Josh Brodsky; Harsha Prabhala; Xuemei Zhang; Husain Attarwala; Renta Hutabarat; Don Foster; Stuart Milstein; Klaus Charisse; Satya Kuchimanchi; Martin A Maier; Lubo Nechev; Pachamuthu Kandasamy; Alexander V Kel'in; Jayaprakash K Nair; Kallanthottathil G Rajeev; Muthiah Manoharan; Rachel Meyers; Benny Sorensen; Amy R Simon; Yesim Dargaud; Claude Negrier; Rodney M Camire; Akin Akinc
Journal:  Nat Med       Date:  2015-04-13       Impact factor: 53.440

10.  The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.

Authors:  D Zamolodchikov; T Renné; S Strickland
Journal:  J Thromb Haemost       Date:  2016-02-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.